Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financia...(r with growth in new markets in Latin Am...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance
Date:4/25/2008
r with growth in new markets in Latin America and Japan. The product is now approved for marketing and commercial distribution in 39 countries.
REPLAGAL - Fabry disease
Sales for the three months to March 31, 2008 were $42.5 million, an increase of 31% compared to the same period in 2007 (2007: $32.5 million). Expressed in transaction currencies (REPLAGAL is primarily sold in Euros and Pounds Sterling) sales increased by 19% primarily due to higher unit sales in Europe and Canada as the Company continues to identify new patients. Exchange rate movements against the US dollar accounted for the remaining 12% increase in sales.
3. Royalties
Royalty revenue increased by 9% to $65.1 million for the three months
to March 31, 2008 (2007: $59.5 million). The following table provides an
analysis of Shire's royalty income:
Royalty Highlights
Royalties
to Shire Royalty
Growth(1)
Product $M %
3TC 37.3 5%(2)
ZEFFIX 10.4 14%(3)
Other 17.4 17%
Total 65.1 9%
(1) Compared with Q1 2007.
(2) Includes favourable foreign exchange movements of 7%
(3) Includes favourable foreign exchange movements of 13%
3TC - HIV infection and AIDS Shire receives royalties from GSK on worldwide 3TC sales. Royalties
from sales of 3TC for the three months to March 31, 2008 were $37.3
million, comparable to the same period in 2007 (2007: $35.5 million).
Excluding favourable foreign exchange movements of 7%, there has been a
decline of 2% compared to the same period in 2007. While the nucleoside
analogue market for HIV has continued to grow, competitive pressures from
new products and entrants to the market have
'/>"/>
| SOURCE Shire plc Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
3. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
4. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
5. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
6. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
7. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
8. Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data
9. ITSSD: Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innovation Model
10. Optherion, Inc. Completes $37 Million Start Up Financing
11. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
Post Your Comments:
(Date:12/16/2009)... conducted pursuant to Special Protocol Assessment with ... CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris ... (the "Company"), a global biopharmaceutical company focused ... the initiation, by its partner Keryx Biopharmaceuticals ... 3 registration clinical trial for perifosine (KRX-0401), ...
(Date:12/15/2009)... Epeius Biotechnologies Corporation, an emerging leader ... international validation of the cutting-edge science behind its ... around the world rediscovered the Cyclin G1 ... cancer pathogenesis and disease progression, and thus a ... the NIH National Cancer Institute investigating the role ...
(Date:12/15/2009)... -- Aethlon Medical, Inc. (OTC Bulletin Board : ... Dr. Wayne Comper have joined the ... Both Dr. Schorey and Dr. Comper are leading ... owned subsidiary of Aethlon Medical, was recently formed ... medical device being advanced as an adjunct therapy ...
(Date:12/15/2009)... 15 The Center for Business ... is pleased to announce the full agenda ... and Reporting Congress . The forum will ... March 16-17, 2010. ,, Over 1,500 senior-level ... attended this premier event since its inception, ...
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2[0] AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma[0] Scientists Rediscover Gene Target for Cancer Therapy[0] Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board[0] CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress
... (Nasdaq:,AMGN) today announced that it plans to report its ... the close of the financial,markets. The announcement will be ... 1:30 p.m. Pacific Time. Participating in the call,from Amgen ... members of,Amgen,s senior management team., Live audio of ...
... industry,and government leaders gathered in Kannapolis, Monday, October ... House celebration for the David H. Murdock,Core Laboratory ... NC,State Fruit and Vegetable Science Institute Building. The ... University, NC Central University, UNC,Chapel Hill and UNC ...
... its newest tenant partner. The NC Research Campus is the vision ... colleges (including Duke University, UNC, and NC State)will have research units located ... to be a world class center for industry and academic research for ... ...
Other Biology Technology:Amgen Announces Webcast of 2008 Third Quarter Financial Results 2Campus Celebrates Historic Milestone 2Campus Celebrates Historic Milestone 3Campus Celebrates Historic Milestone 4Campus Celebrates Historic Milestone 5Food and Beverage Giant Joins Kannapolis Research Center 2Food and Beverage Giant Joins Kannapolis Research Center 3Food and Beverage Giant Joins Kannapolis Research Center 4(Date:12/16/2009)... researcher will lead the coordinating center for a consortium ... of stem cell research. Michael L. Terrin, M.D.,C.M.,M.P.H., professor ... National Heart, Lung and Blood Institute (NHLBI) to coordinate ... will be called the NHLBI Progenitor Cell Biology Consortium. ... million grant over seven years. , ...
(Date:12/16/2009)... 2 DigitalPersona, Inc., a leader ... announced an agreement with IBM to deploy ... fingerprint technology on IBM SurePOS 500 retail ... point-of-sale applications to more easily and quickly ... be linked to the individuals who perform ...
(Date:12/16/2009)... Solutions Inc. is pleased to announce it has ... previously operating as IgeaCare Systems Inc. The newly ... new leadership and funding. ,, IgeaCare Solutions Inc. ... of Chief Executive Officer. Under his direction, the ... servicing and support model; fast and accurate delivery ...
Breaking Biology News(10 mins):University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 1New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 2New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 3New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 4deCODE genetics Inc Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 6316 1deCODE genetics Inc Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 6316 2deCODE genetics Inc Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 6316 3deCODE genetics Inc Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 6316 4Coed college housing connected to frequent binge drinking 61480 1Coed college housing connected to frequent binge drinking 61480 2... N.Y., JAN. 9, 2008 Not enough American women ... day can help prevent serious birth defects, and only ... essential nutrient beginning before pregnancy, two recent surveys show. ... beginning before pregnancy is crucial because birth defects of ...
... at MIT are developing a tiny sensor that could ... including toxic industrial chemicals and chemical warfare agents, much ... taken the common techniques of gas chromatography and mass ... the size of a computer mouse. Eventually, the team, ...
... Cancer patients usually ask what can be done after ... organs. In many cases, they learn, little can be done. ... Spring Harbor Laboratory (CSHL) of a type of cell that ... aggressive metastases the kind that kill cancer patients. ...
Other Biology News:New folic acid seal helps women choose enriched grain foods to help prevent birth defects 2New folic acid seal helps women choose enriched grain foods to help prevent birth defects 3MIT gas sensor is tiny, quick 2CSHL scientists identify cells that promote formation of lethal lung metastases 2...
... designed to rapidly and reliably amplify unknown ... Technology. APAgene provides hassle-free, ready-to use components, ... ingredients are provided in each kit. The ... for insert-end amplification of large clones such ...
N,N'-Methylene-bis-acrylamide, Ultra Pure...
Bovine Calf Serum...
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |